跳至主要内容
临床试验/ACTRN12623000995673
ACTRN12623000995673招募中Unknown

Multidisciplinary Team-based approach to guide secondary risk prevention for cardiovascular and limb outcomes in patients with Peripheral Artery Disease (TEAM-PAD): A Randomised Controlled Trial

Investigator initiated study, sponsored by Vascular Department, Concord Repatriation General Hospital, SLHD0 个研究点目标入组 150 人开始时间: 2023年9月13日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Aged 18 years and above
  • 2. Receiving outpatient care for PAD in the Concord Repatriation General Hospital vascular surgery clinics (in 3 West or High Risk Foot Clinic), inpatient care under the vascular department at Concord Repatriation General Hospital, or directly referred to study investigators from private consulting rooms of Concord Repatriation General Hospital affiliated vascular surgeons.
  • OR Receiving outpatient care for PAD in the Royal Prince Alfred Hospital vascular surgery clinics (or High Risk Foot Clinic)
  • OR Receiving outpatient care for PAD in the Nepean Hospital vascular surgery clinics (or High Risk Foot Clinic)
  • 3. Evidence of PAD defined by either Ankle Brachial Index (ABI) < 0.9 or Toe Brachial Index (TBI) < 0.6
  • OR Previous vascular surgical or endovascular intervention for PAD
  • OR Other means of diagnosing PAD (medical imaging, clinical grading)

排除标准

  • 1. Patients who do not provide consent due to incapacity to consent or who decline to participate.
  • 2. Patients who have a life limiting condition (terminal illness or estimated life expectancy less than one year) and would not benefit from being included in the study.

研究者

发起方
Investigator initiated study, sponsored by Vascular Department, Concord Repatriation General Hospital, SLHD

相似试验